Contract manufacturing said to be slowing; Lubrizol buys Particle Sciences;

> A new industry report says that growth of the biopharmaceutical contract manufacturing sector is likely to be slow because of high levels of capital investment by drugmakers. Report

> Bethlehem, PA-based CDMO Particle Sciences has been acquired by Lubrizol. Report

> A new report estimates that between 27% and 30% of India's $15 billion domestic drug business is controlled by foreign nationals. Release

> India is considering having thousands of drugmakers upgrade to PICS standards to help them access about 45 export markets. Report

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.